Study Results
Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.
View full resultsBasic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
TERMINATED
NA
59 participants
INTERVENTIONAL
2010-11-30
2012-06-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Clinical Evaluation of the SNaP Wound Care System
NCT01113658
SNaP Wound Care System Over Skin Cancer Excision Sites and Split Thickness Skin Grafts (STSGs)
NCT01349894
Post-Market Clinical Evaluation of the Spiracur SNaP Wound Care System for Treatment of Acute Trauma and Acute Surgical Excision Wounds
NCT01417234
Activated Carbon Interphase Effect on Surgical Incisions vs.Two Common Wound Dressings
NCT04038671
Feasibility Study of a Novel Device for Chronic Wounds
NCT00660049
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
ciSNaP
ciSNaP
SNaP disposable, mechanically powered Negative Pressure Wound Therapy System
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
ciSNaP
SNaP disposable, mechanically powered Negative Pressure Wound Therapy System
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Subject is 18 years of age or older.
* Subject consents to follow-up per protocol.
* Willing and able to sign informed consent.
Exclusion Criteria
* Subject has wounds with exposed blood vessels not suitable for negative pressure therapy.
* Pregnant or pregnancy-suspected subject.
* Subject actively participating in other clinical trials that conflict with the current study.
* Subject is unable or unwilling to comply with protocol requirements.
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
3M
INDUSTRY
KCI USA, Inc
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
El Camino Hospital
Mountain View, California, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
030110
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.